With Stars Aligned And Cash In Reserve, Bob Nelsen’s Resilience Plans A Makeover At 2 New Facility Additions To Its Drug Manufacturing Upstart
Read on
NEWS
Resilience Expands North American Capacity With The Acquisition Of Two Premier Biologics Manufacturing Facilities
Resilience announces the acquisition of two biologics manufacturing facilities in North America.
Fireside Chat With Rahul Signhvi, CEO Of Resilience
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member...
Resilience Bags Sanofi-Genzyme Plant In Boston
Newly formed CDMO Resilience takes over the once-troubled Allston facility in Massachusetts from Sanofi, retaining all 250 staff.
Sanofi Prepares To Transfer Allston Plant To A New Company, But Not Its City Tax Breaks
Resilience’s interest in the 310,000-square-foot plant overlooking the Charles River provides further confirmation that this area in North Allston is...
Raging At The Pandemic, A VC Raises $800M For A Company That Aims To Transform Biotech Manufacturing
The board of the new company, Resilience, includes a who’s who of former industry and government officials.
